Bob is a seasoned pharmaceutical executive with broad business and product management experience.
He is the Chief Executive Officer of Cirius Therapeutics and an Entrepreneur-in-Residence with Frazier Healthcare Partners. Bob previously served as Chief Executive Officer of Laguna Pharmaceuticals and Chief Executive Officer of Amira Pharmaceuticals until its $475 million acquisition by Bristol-Myers Squibb in 2011. Prior to his tenure at Amira, Bob held a number of senior management positions over 17 years at Amgen. Bob received his MBA from the Anderson School at the University of California, Los Angeles, and an MS in genetics and a BS in microbiology from The Pennsylvania State University.